Champions Oncology Inc stock is traded at $4.76, with a volume of 9,307. It is down -1.45% in the last 24 hours and down -4.99% over the past month. Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Previous Close:
$4.83
Open:
$4.76
24h Volume:
9,307
Relative Volume:
1.04
Market Cap:
$66.25M
Revenue:
$57.94M
Net Income/Loss:
-$2.34M
P/E Ratio:
-
EPS:
-$0.1666
Net Cash Flow:
$3.82M
1W Performance:
-1.04%
1M Performance:
-4.99%
6M Performance:
-20.40%
1Y Performance:
-30.81%
1-Day Range:
$0.00$0.00
1-Week Range:
$4.72$5.06
52-Week Range:
$4.59$8.31
Champions Oncology Inc Stock (CSBR) Company Profile
Name
Champions Oncology IncSector
HealthcareIndustry
BiotechnologyPhone
410-369-0365Address
855 N. WOLFE STREET, BALTIMORE, NJ, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS